ALEXANDRIA, Va., June 6 -- United States Patent no. 12,282,022, issued on April 22, was assigned to THE METHODIST HOSPITAL (Houston).
"Nanoplasmonic quantification of tumor-derived extracellular vesicles in plasma microsamples for detection and treatment monitoring" was invented by Ye Hu (Scottsdale, Ariz.), Jia Fan (Pearland, Texas), Kai Liang (Beijing), Fei Liu (Cupertino, Calif.) and Dali Sun (Tempe, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A rapid, ultrasensitive and inexpensive nanoplasmon-enhanced scattering (nPES) assay that directly quantifies tumor-derived EVs from as little as 1 Mu{umlaut over ({acute over (Iota)})}, of plasma is described herein. This assay uses binding of gold nanosph...